The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers

A Sansone, D Mollaioli, E Limoncin… - Sexual Medicine …, 2022 - academic.oup.com
Introduction Long term complications of COVID-19, the disease caused by the SARS-CoV-2,
involve many organ systems, dramatically worsening the quality of life, and finally …

Targeting the 26S proteasome to protect against proteotoxic diseases

N Myeku, KE Duff - Trends in molecular medicine, 2018 - cell.com
Aggregates of misfolded proteins can compromise the function of the 26S proteasome
complex, leaving neurons susceptible to accelerated and impaired protein homeostasis …

Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat

MG Ferrini, I Kovanecz, S Sanchez… - Biology of …, 2007 - academic.oup.com
Aging-related erectile dysfunction is characterized by a loss of smooth muscle cells (SMCs)
and fibrosis in the corpora cavernosa, and functionally by corporal veno-occlusive …

Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a …

S Limoncella, C Lazzaretti, E Paradiso… - Molecular and cellular …, 2022 - Elsevier
Abstract Type 5 phosphodiesterase (PDE5) blockade by inhibitors (PDE5i) results in
intracellular cyclic guanosine monophosphate (cGMP) increase and smooth muscle …

Prostacyclin analogues inhibit platelet reactivity, extracellular vesicle release and thrombus formation in patients with pulmonary arterial hypertension

A Gąsecka, M Banaszkiewicz, R Nieuwland… - Journal of Clinical …, 2021 - mdpi.com
(1) Background: Prostacyclin analogues (epoprostenol, treprostinil, and iloprost) induce
vasodilation in pulmonary arterial hypertension (PAH) but also inhibit platelet function.(2) …

Drug-induced thrombosis: an update

Y Ramot, A Nyska, G Spectre - Drug safety, 2013 - Springer
Drugs may play an important role in development of thrombosis, and in recent years there
has been increased attention to the importance of this issue. Although drug-induced …

Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review

NFS da Cruz, MU Polizelli, LM Cezar… - International Journal of …, 2020 - Springer
To provide information on the effects of phosphodiesterase type 5 (PDE5) inhibitors on
choroidal vessels and central serous chorioretinopathy (CSC) and possible implications for …

Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects

C Foresta, N Caretta, D Zuccarello, A Poletti, A Biagioli… - Eye, 2008 - nature.com
Objective We tested the effect of two phosphodiesterase type-5 (PDE5) inhibitors, sildenafil
and tadalafil, on ophthalmic artery (OA) blood flow velocity and investigated the presence of …

A gas chromatography/mass spectrometry method for the determination of sildenafil, vardenafil and tadalafil and their metabolites in human urine

S Strano‐Rossi, L Anzillotti… - … in Mass Spectrometry, 2010 - Wiley Online Library
Abstract Sildenafil (SDF), vardenafil (VDF) and tadalafil (TDF) are phosphodiesterase type 5
enzyme inhibitors (PDE5Is), used in the treatment of erectile disorders and to improve …

Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain

O Ozdegirmenci, T Kucukozkan, E Akdag… - The Journal of …, 2011 - Taylor & Francis
Objective. The aim of the present study was to evaluate the effects of phosphodiesterase
type 5 (PDE5) inhibitory drugs, sildenafil and tadalafil, in ischemia/reperfusion (I/R)-induced …